Safehold Inc. (NYSE: SAFE) reported results for the fourth quarter and fiscal year ended December 31, 2024. https://mma.prnewswire.com/media/2039387/Safehold__Carbon_Logo.jpg SAFE published a presentation detailing these results which can be found on its website, www.safeholdinc.comin the “Investors” section. Highlights from the earnings announcement include: — Q4'24 revenue was $91.9 million, and FY'24 was $365.7 million — Q4'24 […]
Etsy, Inc. (Nasdaq: ETSY), which operates two-sided online marketplaces that connect millions of passionate and creative buyers and sellers around the world, plans to release its fourth quarter and year end 2024 financial results before the opening of the market on Wednesday, February 19, 2025. The press release can be accessed on the Etsy Investor
Proxy Statement Includes Proposals on Previously Announced Sale of FYARRO and Associated Infrastructure to Kaken for $100M, and $100M PIPE Financing to Support In-Licensing of ADC Portfolio Aadi's Board Recommends Stockholders Vote “FOR” All Proposals to Support the Company's Business Transformation Company Expects to Close Transactions in the First Quarter of 2025, Subject to Stockholder
ThirdQuarter Revenue Totaled $134.6 Million ThirdQuarter GAAP Net Loss of $23.1 Million, or GAAP EPS of ($0.22); Third Quarter Non-GAAP Adjusted Net Income1 of $13.7 Million and Non-GAAP Adjusted EPS1 of $0.13 ThirdQuarter Non-GAAP Adjusted EBITDA2 Totaled $22.0 Million Digital Turbine, Inc. (Nasdaq: APPS) announced financial results for the fiscal third quarter ended December 31,
Conference call scheduled for 4:30 p.m. ET today — Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 — Phase 2 VENTURE-Oral Dosing Trial Evaluating VK2735 in Obesity Underway — Strong Year-End Cash Position of $903 Million Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development
Delivers Financial and Operational Outperformance in Fiscal Q1; Raises Fiscal 2025 Guidance Ranges for All Metrics Universal Technical Institute, Inc. (NYSE: UTI), a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, reported financial results for the fiscal 2025 first quarter ended December31, 2024. Universal Technical Institute, Inc. operates in tworeportable segments,
Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended December 31, 2024. https://mma.prnewswire.com/media/1008600/Envista_Logo.jpg “In Q4 2024, Envista delivered results that were in line with expectations, indicating that our focus on growth, operations, and people is having a positive impact,” said Paul Keel, Envista's CEO. “2024 was a transition year for our company.
Renibus Therapeutics® (“Renibus”), a clinical-stage biopharmaceutical company focusingon the prevention and treatment of cardiac, renal, and metabolic diseases, today announced its participation in Oppenheimer's 35th Annual Healthcare Life Sciences Conference, being held February 11-12, 2025, in a virtual format. Jeffrey Keyser, RPh, JD, PhD, President and CEO of Renibus, will present on Wednesday, February 12,
Regal Rexnord Corporation (NYSE: RRX) 4Q Highlights — Diluted EPS Of $0.62; Adjusted Diluted EPS* Of $2.34, Up 2.6% Versus PY — Paid Down $205 Million Of Gross Debt In 4Q. Net Debt/Adjusted EBITDA (Including Synergies)* Of ~3.6x — Cash From Operating Activities Of $213.2 Million; Adjusted Free Cash Flow* Of $185.3 Million, Up 8.4%
Revenues increased 14% for the quarter compared to prior year and 13% year-to-date Positive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024 Year-to-date net loss decline of $1.1 million BOULDER, CO / ACCESS Newswire / February 5, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader